1. Catalogs
  2. Accuray
  3. Radixact®

Radixact®

Radixact®

Radixact®

Product catalog summary
Introduction
The document discusses the Radixact® System, a next-generation TomoTherapy® platform, focusing on its impact on the consumerization of healthcare, especially in radiation therapy (RT) for cancer treatment. It highlights the shift in patient expectations towards more innovative, convenient, and value-driven healthcare services.

Consumerization of Healthcare
Patients now expect healthcare services to match the convenience and service level of other industries, with many seeking innovative technologies and shorter treatment schedules. This trend is reshaping radiation oncology practices.

The Radixact® System
The Radixact® System is designed to meet these new patient expectations by offering:
  • Versatility: Capable of treating a wide range of clinical indications with various imaging and delivery modalities.
  • Intelligence: Features automated patient monitoring and real-time delivery adaptation for personalized treatments.
  • Efficiency: Provides fast planning, imaging, and delivery, enhancing patient throughput and clinical outcomes.


Patient Outcomes
The system aims to deliver outcomes that matter most to patients, including:
  • Proven Cancer Control: Supported by clinical evidence, it offers effective cancer control with reduced side effects.
  • Personalized Treatment: Tailors treatment plans to individual patient anatomy and tumor characteristics.
  • Improved Quality of Life: Minimizes side effects, enhancing patient quality of life during and after treatment.
  • Less Disruptive Treatment: Offers non-invasive, outpatient treatments with reduced session requirements.


Cost Considerations
The document addresses the importance of cost discussions with patients, highlighting how the Radixact System can lower patient costs through outpatient treatment options and reduced side effects.

Precision and Efficiency
The Radixact System's precision in targeting tumors reduces collateral damage and recurrence risk, offering efficient treatments to more patients at a lower cost.

Conclusion
Accuray, the company behind the Radixact System, is committed to continuous innovation in radiation therapy, aiming to improve patient outcomes and expand the potential of radiation therapy globally.
See more

Catalog excerpts

Radixact®-1

The Radixact® System, The Next-generation TomoTherapy® Platform Positioning Your Practice for the Age of Patient Choice

 Open the catalog to page 1
Radixact®-2

Consumerization of Healthcare Reshapes Expectations The consumerization of healthcare is now a firmly established phenomenon across all fields, including radiation oncology. Today’s patient-as-consumer has had their expectations “Amazon Primed.” More than 75% of healthcare consumers believe that they should receive the same level of service and value in healthcare as they receive from other businesses1. DUCT & TECHNOLOGY ICONS Patients Seek Out Radiation Therapy (RT) Centers Key findings from 2017 study of prostate cancer patients seeking RT treatment . CHNOLOGY & SERVICES ICONS 2 1 in 5 patients...

 Open the catalog to page 2
Radixact®-3

The Radixact® System Unlocks Patient Outcomes that Matter Most The unique treatment capabilities of the Radixact System enable your practice to provide treatments that deliver the critical outcomes that today's patients-as-consumers are seeking: More than anything, patients want to beat their cancer — and today's highly informed patients-as-consumers want to see the clinical proof. The Radixact® System with TomoTherapy® technology is supported by two decades of published clinical followup, providing real-world evidence that the Radixact® System can deliver excellent cancer control with reduced...

 Open the catalog to page 3
Radixact®-4

Show Your Patients Why Precision Matters Clinicians understand that more-precise treatment options like those enabled by the Radixact® System deliver a range of complex benefits. But here is a simple graphical way to show your patients why precision matters: Greater Precision Better Cancer Control Lower Risk of Recurrence Less Collateral Damage Better Targeting Breaking the Taboo: Having the Cost Conversation While providers have traditionally shied away from discussing cost of care with patients, today 80% of patients expect their doctors to clearly communicate the patient’s financial responsibility...

 Open the catalog to page 4
Radixact®-5

Confident Precision — Without Tradeoffs The automatic, AI-driven, real-time motion synchronization and treatment delivery adaptation of the Radixact® System with Synchrony®* technology introduces a new paradigm: no-tradeoff radiation therapy. This advanced technology may be new to patients, but the implications for their quality of care are very relevant. Natural Patient Behavior Greater Patient Comfort Improving the Patient Experience Efficient Continuous Delivery More Efficient Treatments to More Patients at a Lower Cost Minimal Margins Potential for Better Clinical Outcomes with Fewer Side...

 Open the catalog to page 5
Radixact®-6

Accuray is committed to expanding the powerful potential of radiation therapy to improve as many lives as possible. We invent unique, market-changing solutions that are designed to deliver radiation treatments for even the most complex cases — while making commonly treatable cases even easier — to meet the full spectrum of patient needs. We are dedicated to continuous innovation in radiation therapy for oncology, neuro-radiosurgery, and beyond, as we partner with clinicians and administrators, empowering them to help patients get back to their lives, faster. Accuray is headquartered in Sunnyvale,...

 Open the catalog to page 6

All Accuray catalogs and technical brochures

  1. CyberKnife®

    5  Pages

  2. PreciseRTX®

    1  Page

  3. PreciseART®

    2  Pages

  4. Radixact™

    6  Pages

*Prices are pre-tax. They exclude delivery charges and customs duties and do not include additional charges for installation or activation options. Prices are indicative only and may vary by country, with changes to the cost of raw materials and exchange rates.